TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
JMVA Biotech AB
Closing information (x1000 DKK)
| Closing information | 2022/12 | 2021/12 | 2020/12 |
| Turnover |
862
|
939
|
1,398 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
242
|
159
|
588 |
| EBITDA |
240
|
159
|
588 |
| Total assets |
1,464
|
1,735
|
1,741 |
| Current assets |
1,464
|
1,735
|
1,741 |
| Current liabilities |
10
|
142
|
22 |
| Equity capital |
1,410
|
1,545
|
1,670 |
| - share capital |
33
|
36
|
37 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Solvency |
96.3%
|
89.0%
|
95.9% |
| Turnover per employee |
862
|
939
|
1,398 |
| Profit as a percentage of turnover |
28.1%
|
16.9%
|
42.1% |
| Return on assets (ROA) |
16.5%
|
9.2%
|
33.8% |
| Current ratio |
14640.0%
|
1221.8%
|
7913.6% |
| Return on equity (ROE) |
17.2%
|
10.3%
|
35.2% |
| Change turnover |
-1
|
-432
|
-128 |
| Change turnover % |
0%
|
-31%
|
-8% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.